Literature DB >> 15683418

Pseudomembranous colitis in children.

Itzhak Brook1.   

Abstract

This review presents the microbiology, management and prevention of pseudomembranous colitis (PMC) in children. PMC is commonly associated with prior antibiotic exposure and hospitalization. It is caused almost exclusively by toxins produced by Clostridium difficile. The clinical spectrum of this disease may range from a mild, non-specific diarrhea to severe colitis with toxic megacolon, perforation, and death. PMC may affect all age groups, although a lower incidence has been noted in children. Ampicillin, amoxicillin, the second- and third-generation cephalosporins and clindamycin are the drugs most frequently associated with development of PMC, although nearly all antimicrobials have been implicated as causes of diarrhea and colitis. Discontinuation of antibiotics and supportive therapy usually lead to resolution of this disorder. Administration of oral vancomycin or other therapeutic regimens may be needed.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15683418     DOI: 10.1111/j.1440-1746.2004.03466.x

Source DB:  PubMed          Journal:  J Gastroenterol Hepatol        ISSN: 0815-9319            Impact factor:   4.029


  9 in total

Review 1.  Use of ciprofloxacin during breastfeeding.

Authors:  Yusuf Cem Kaplan; Gideon Koren
Journal:  Can Fam Physician       Date:  2015-04       Impact factor: 3.275

Review 2.  Ways to Improve Insights into Clindamycin Pharmacology and Pharmacokinetics Tailored to Practice.

Authors:  Laura Armengol Álvarez; Greet Van de Sijpe; Stefanie Desmet; Willem-Jan Metsemakers; Isabel Spriet; Karel Allegaert; Jef Rozenski
Journal:  Antibiotics (Basel)       Date:  2022-05-21

3.  Clostridium difficile infection in Polish pediatric outpatients with inflammatory bowel disease.

Authors:  D Wultańska; A Banaszkiewicz; A Radzikowski; P Obuch-Woszczatyński; G Młynarczyk; J S Brazier; H Pituch; A van Belkum
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2010-06-26       Impact factor: 3.267

Review 4.  Hirschsprung-associated enterocolitis: prevention and therapy.

Authors:  Philip K Frykman; Scott S Short
Journal:  Semin Pediatr Surg       Date:  2012-11       Impact factor: 2.754

5.  Reducing Broad-Spectrum Antibiotic Treatment of Simple Group A Streptococcal Infections to Reduce Harm to the Microbiome.

Authors:  Tyrone J Sumibcay; Jannet J Lee-Jayaram; Loren G Yamamoto
Journal:  Cureus       Date:  2021-06-13

6.  What is the 'objective' differential factor of diarrhea in infancy?: Normal state versus diarrheal illness in infants with chronic frequent and loose stool.

Authors:  Jin-Bok Hwang; Kyung Ji Kang; Jung Jeung Lee; Ae Suk Kim
Journal:  Korean J Pediatr       Date:  2010-12-31

7.  Complete Genome Sequence of the Hypervirulent Bacterium Clostridium difficile Strain G46, Ribotype 027.

Authors:  Tom Gaulton; Raju Misra; Graham Rose; Primo Baybayan; Richard Hall; Jane Freeman; Jane Turton; Steve Picton; Jonas Korlach; Saheer Gharbia; Haroun Shah
Journal:  Genome Announc       Date:  2015-03-26

8.  Healthcare-associated infections in pediatric cancer patients: results of a prospective surveillance study from university hospitals in Germany and Switzerland.

Authors:  Arne Simon; Roland A Ammann; Udo Bode; Gudrun Fleischhack; Hans-Martin Wenchel; Dorothee Schwamborn; Chara Gravou; Paul-Gerhardt Schlegel; Stefan Rutkowski; Claudia Dannenberg; Dieter Körholz; Hans Jürgen Laws; Michael H Kramer
Journal:  BMC Infect Dis       Date:  2008-05-23       Impact factor: 3.090

Review 9.  Clostridium difficile infection: a review of current and emerging therapies.

Authors:  Andrew Ofosu
Journal:  Ann Gastroenterol       Date:  2016 Apr-Jun
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.